Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pregnancy Followed”

703 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 703 results

Testing effectiveness (Phase 2)Study completedNCT00191711
What this trial is testing

Intravesical Gemcitabine Instillation Followed by Transurethral Resection for the Treatment of Patients With Superficial Bladder Cancer at Low Risk.

Who this might be right for
Superficial Bladder Cancer
Eli Lilly and Company 43
Testing effectiveness (Phase 2)Study completedNCT00490711
What this trial is testing

Treatment of Paclitaxel Plus Carboplatin Followed by Gemcitabine Plus Carboplatin for Patients With Epithelial Ovarian Cancer

Who this might be right for
Epithelial Ovarian Cancer
Eli Lilly and Company 7
Not applicableLooking for participantsNCT04901351
What this trial is testing

Multi-site HPV Screening by High-throughput Sequencing in Patients With Chronic HPV-HR Infection Followed by Gynecology

Who this might be right for
Human Papillomavirus
University Hospital, Toulouse 30
Testing effectiveness (Phase 2)Ended earlyNCT04578548
What this trial is testing

Evaluate the Effects of GLPG2737 in Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease
Galapagos NV 66
Not applicableStudy completedNCT03664258
What this trial is testing

A Multi-National Study In Bladder Cancer Patients to Detect Recurrences After TURB (Trans-urethral Resection of the Bladder) Earlier With the Xpert Bladder Cancer Monitor Assay (ANTICIPATE X)

Who this might be right for
Non-muscle-invasive Bladder Cancer
Cepheid 852
Testing effectiveness (Phase 2)Study completedNCT00511992
What this trial is testing

Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian Cancer

Who this might be right for
Advanced Ovarian CarcinomaPrimary Peritoneal CarcinomaOvarian Carcinosarcoma
University of Oklahoma 20
Post-approval studies (Phase 4)Study completedNCT00129506
What this trial is testing

Comparing Methotrexate Followed by Misoprostol to Misoprostol Alone for Early Abortion

Who this might be right for
Unwanted Pregnancies
Wiebe, Ellen, M.D. 300
Large-scale testing (Phase 3)Active Not RecruitingNCT02859038
What this trial is testing

Study of Upfront Surgery Versus Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer (SUNNY)

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma
Shanghai Gynecologic Oncology Group 489
Not applicableUnknownNCT00358891
What this trial is testing

Follow-Up of VLBW Infants With Chronic Lung Disease: Respiratory Health and Neurodevelopment

Who this might be right for
Premature Birth
National Taiwan University Hospital 98
Testing effectiveness (Phase 2)Study completedNCT02150213
What this trial is testing

Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492

Who this might be right for
Adrenocortical AdenomaEndometrial Stromal Sarcomas
Novartis Pharmaceuticals 59
Not applicableStudy completedNCT06915779
What this trial is testing

Long Term Follow-up of HPV Vaccine in HIV (CTN 236)

Who this might be right for
Cervical CancerHuman Papillomavirus InfectionHuman Immunodeficiency Virus+2 more
University of British Columbia 241
Not applicableStudy completedNCT03542513
What this trial is testing

First-void Urine Samples for the Follow-up of Women Treated for High-grade Cervical Intraepithelial Neoplasia (CIN)

Who this might be right for
Cervical Cancer
Universiteit Antwerpen 65
Large-scale testing (Phase 3)Study completedNCT00915525
What this trial is testing

Long Term Follow-up Study of Safety and Efficacy of Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence

Who this might be right for
Overactive BladderUrinary Incontinence
Allergan 829
Testing effectiveness (Phase 2)Active Not RecruitingNCT06419673
What this trial is testing

Serplulimab Plus Chemoradiotherapy for Stage III-IVA Cervical Cancer

Who this might be right for
Cervical Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 240
Not applicableUnknownNCT03302624
What this trial is testing

Follow-up of Long-term Renal Function After Acute Kidney Injury in ICU

Who this might be right for
Acute Kidney InjuriesQuality of LifeChronic Kidney Disease+1 more
University Hospital, Clermont-Ferrand 506
Not applicableUnknownNCT00310869
What this trial is testing

Adolescents Born Preterm; Nurtured Beginnings

Who this might be right for
Preterm Birth
Boston Children's Hospital 70
Testing effectiveness (Phase 2)Study completedNCT00112086
What this trial is testing

OVCA-NAC-P2: Study of Chemotherapy Followed by Cytoreductive Surgery for Ovarian, Tubal and Peritoneal Cancers: JCOG0206

Who this might be right for
Ovarian NeoplasmsFallopian Tube NeoplasmsPeritoneal Neoplasms
Japan Clinical Oncology Group 56
Not applicableLooking for participantsNCT00009633
What this trial is testing

Follow-up Visit of High Risk Infants

Who this might be right for
Infant, NewbornInfant, Low Birth WeightInfant, Small for Gestational Age+1 more
NICHD Neonatal Research Network 68,000
Testing effectiveness (Phase 2)Study completedNCT00003406
What this trial is testing

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
Cancer Treatment Centers of America 30
Not applicableStudy completedNCT01149291
What this trial is testing

Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism

Who this might be right for
Secondary HyperparathyroidismEnd Stage Renal Disease
AbbVie (prior sponsor, Abbott) 511
Load More Results